CAMBRIDGE, Mass., Sept. 30, 2024 (GLOBE NEWSWIRE) -- (Korro) (Nasdaq: KRRO) a biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and ...
at Number 1 in the UK. This now means that Sabrina has ... NDOTZ celebrates his first UK Top 20 single today with Embrace It, vaulting up 16 spots (20), becoming a landmark moment for the ...
Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary diseases, announced today the company will present a poster and ...